Pharmacology: 17β-estradiol induces gastrointestinal motility disorder by decreasing CPI-17 phosphorylation via changes in Rho-family G-protein Rnd expression in small intestine

DOI Web Site Web Site 被引用文献1件 参考文献23件
  • SHIMOMURA Aya
    Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
  • OHAMA Takashi
    Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
  • HORI Masatoshi
    Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
  • OZAKI Hiroshi
    Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo

書誌事項

タイトル別名
  • 17.BETA.-Estradiol Induces Gastrointestinal Motility Disorder by Decreasing CPI-17 Phosphorylation Via Changes in Rho-Family G-Protein Rnd Expression in Small Intestine
  • Pharmacology 17 v estradiol induces gastrointestinal motility disorder by decreasing CPI 17 phosphorylation via changes in Rho family G protein Rnd expression in small intestine

この論文をさがす

抄録

In the present study, we investigated the long-term effects of 17β-estradiol on the motility of small intestine in in vitro organ culture and in vivo treatment studies. When rat ileal circular smooth muscle tissues were cultured with 17β-estradiol (0.1 and 1 μM) for 5 days, carbachol-induced contraction was inhibited. In ileal tissue isolated from ovariectomized rat treated with 17β-estradiol (200 μg/kg/day s.c. for 3 days), carbachol-induced contraction was also impaired. Both in vitro and in vivo, 17β-estradiol treatment upregulated heat shock protein 27 (HSP27) expression, indicating the activation of estrogen receptor in the intestinal smooth muscle. 17β-estradiol did not change protein expression levels of RhoA and RhoA-associated coiled coil-forming serine/threonine kinases (ROCKs); however, it upregulated Rnd2 and Rnd3, Rho-family G-proteins that counteract the functions of RhoA, both in vitro and in vivo. In organ culture, treatment of ileal tissue with 17β-estradiol greatly suppressed the carbachol-induced increase in phosphorylation at Thr38 in CPI-17 without altering total CPI-17 protein expression. These results suggest that 17β-estradiol upregulates Rnd expression to inhibit the RhoA-mediated Ca2+ sensitization of contractile mechanisms, which are mediated by CPI-17 phosphorylation in ileal smooth muscle. This mechanism may contribute to the intestinal motility disorder occurring in gender-dependent bowel diseases.<br>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (23)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ